<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02794766</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE40334914000005342</org_study_id>
    <nct_id>NCT02794766</nct_id>
  </id_info>
  <brief_title>Inulin and S. Salivarius Reduce Halitosis</brief_title>
  <official_title>Inulin and Streptococcus Salivarius Reduce Halitosis Associated With Tongue Coating: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade de Passo Fundo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade de Passo Fundo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Halitosis associated with tongue coating results from the production of volatile sulfur&#xD;
      compounds by bacterial action. The use of prebiotics and probiotics might be useful in&#xD;
      treating such condition. The aim of this study was to evaluate the effect of the prebiotic&#xD;
      inulin combined with the probiotic Streptococcus salivarius (SS) on halitosis by coating.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants In this randomized, controlled, double-blind, parallel, phase II clinical trial,&#xD;
      adult patients (≥18 years old) who complained of halitosis in the presence of tongue coating&#xD;
      were invited to participate. They were identified with invitations in the form of posters&#xD;
      distributed at the Dental School clinics, University of Passo Fundo (UPF), from August to&#xD;
      November, 2015. The Dental School is located on the main campus of UPF,Passo Fundo, a city&#xD;
      with &gt;200.000 habitants. Oral halitosis was initially diagnosed by oral examination for&#xD;
      tongue coating identification, followed by organoleptic test to confirm the halitosis. Total&#xD;
      sample size was estimated in 45 participants, considering a difference of 80% in Halimeter&#xD;
      reduction between treatments, for tests with α = 5% and power = 80%. Halitosis was defined by&#xD;
      Halimeter values ≥ 75 ppb. All participants gave written consent before entering the study.&#xD;
      The research protocol was approved by the local ethics committee (CAAE:&#xD;
      40334914.0.0000.5342).&#xD;
&#xD;
      Clinical examination Oral examination was performed by a trained dentist (CRM), identifying&#xD;
      dental cavities, plaque, gingivitis, periodontal pockets and any dental prosthesis. Coating&#xD;
      was described after visual inspection of the tongue and coating index was classified into 4&#xD;
      levels: 0 - no coating; 1 - thin coating on 1/3; 2 - thin coating on more than 1/3 or thick&#xD;
      coating on only 1/3; 3 - thick coating on more than 1/3.5&#xD;
&#xD;
      Evaluation of halitosis After clinical examination, halitosis was quantified by organoleptic&#xD;
      and Halimeter‡ tests. These were performed by a trained and calibrated examiner (CRM), with&#xD;
      levels of agreement and reproducibility greater than 80% for organoleptic test and coating&#xD;
      index, using test and retest comparisons with an expert judge (CKR). All patients were&#xD;
      examined between 8 and 11 am. Patients were asked to avoid eating garlic, onion and other&#xD;
      food condiments for two days before testing and avoid overeating margarine, milk, fry,&#xD;
      sardines, salami, bologna, sausage, red meat, cheeses, foods with sulfur in the composition&#xD;
      (cabbage, broccoli, cauliflower, egg), drinking alcohol and smoking, following protocols&#xD;
      reported elsewhere.5, 13, 15 In the examination morning, patients should avoid using candies&#xD;
      and gums, but were allowed to have breakfast and tooth brushing with water only. Once&#xD;
      included in the study, patients were asked to avoid gums other than those provided in the&#xD;
      trial.&#xD;
&#xD;
      Organoleptic test Patients at rest were instructed to hold air in the mouth while breathing&#xD;
      through the nose for 1 min. They blow through mouth with the examiner (CRM) positioned 10 cm&#xD;
      from the patient mouth. Patient breath was rated from 0 to 5, as follows: 0 - no smell, 1 -&#xD;
      poor barely perceptible odour, 2 - slight stench, 3 - moderate smelly, 4 - strong stench, and&#xD;
      5 - severe stench.21 With the purpose of selecting patients, halitosis was considered present&#xD;
      when this score was equal or higher than 1 in the presence of tongue coating.&#xD;
&#xD;
      Halimeter Patients had their breath objectively measured using a Halimeter, capable of&#xD;
      measuring the VSC level. Halitosis is identified when the device registers ≥75 ppb.1, 22 The&#xD;
      measurements were made by inserting a disposable straw into the patient mouth above the&#xD;
      tongue. According to the manufacturer, the final result was obtained as the average of three&#xD;
      measurements.&#xD;
&#xD;
      Prebiotic, probiotic and placebo Lactobacillus salivarius G60, inulin and placebo§ (composed&#xD;
      of gomagron) were prepared in the form of gum‖, identical in physical appearance, odour,&#xD;
      taste and consistency making the following experimental groups: LS+inulin: Lactobacillus&#xD;
      salivarius G60 1 billion colony forming units (CFU) + inulin 1 g; LS: Lactobacillus&#xD;
      salivarius G60 1 billion CFU; and placebo. Patients were instructed to use 1 gum every 12 h&#xD;
      (after breakfast and after dinner) for 10 days.&#xD;
&#xD;
      Quality of life assessment For oral related quality of life (QOL), we applied the&#xD;
      questionnaire OHIP-14, translated and validated to Brazilian Portuguese.23 The final score&#xD;
      range from 0 (best) to 56 (worst). Participants responded the questionnaires on days 0 and&#xD;
      14.&#xD;
&#xD;
      Study protocol Patients were evaluated in a dental clinic, following the steps illustrated in&#xD;
      Figure 2. After signing the informed consent, clinical and quality of life data were&#xD;
      recorded, followed by oral examination to assess tongue coating, and organoleptic test to&#xD;
      confirm halitosis. Afterwards, the Halimeter was used to objectively measure halitosis.&#xD;
&#xD;
      Enrolled patients were randomized by the examiner (CRM) using an envelope code that was&#xD;
      computer generated, organized by the gums manufacturer in blocks for 3 patients 1:1:1, each&#xD;
      containing one of the 3 treatments (LS+inulin, LS and placebo). Therefore, examiner and&#xD;
      participants were blinded to treatments. Patients were instructed to use 1 gum every 12 hours&#xD;
      starting on the fourth day after the interview, and interrupting 2 weeks after the first&#xD;
      interview (10 days treatment). This delay of 4 days before starting the treatment allowed an&#xD;
      interval of 14 days for attenuation of recall bias with OHIP-14. Each gum was placed in the&#xD;
      mouth to complete dissolution, allowing gentle mastication. The final examination was&#xD;
      performed in the last day of treatment, 12 hours after using the last gum, repeating coating&#xD;
      index, organoleptic and Halimeter tests, and quality of life assessment (OHIP-14).&#xD;
      Instructions about oral hygiene were provided by the examiner (CRM): patients were asked to&#xD;
      avoid any new approach that could alter halitosis, such as tongue cleaning or changes in&#xD;
      routine tooth brushing. Treatment adherence was assessed as the number of gums not used in&#xD;
      relation to the total number of gums received. Safety was characterized according to side&#xD;
      effects described by the patients, including headache, oral complaints and abdominal symptoms&#xD;
      (yes/not). Primary outcomes were organoleptic test, Halimeter and coating index, whereas&#xD;
      secondary outcomes were quality of life and treatment adherence/safety. Allocation into the&#xD;
      three treatment groups was revealed only after termination of data analysis.&#xD;
&#xD;
      Metabolism of inulin by Lactobacillus salivarius G60 The capacity of Lactobacillus salivarius&#xD;
      G60 to metabolize inulin as a carbon source was tested by inoculating 50 ml of bacterial&#xD;
      suspension LS (1x10⁸-⁹ cells/ml) in buffered physiological saline solution in 5 ml of&#xD;
      environment half-defined by the limit of detection of the method (LDM) without glucose and&#xD;
      sucrose but supplemented with inulin. The following culture mediums were prepared: PYG&#xD;
      (peptone yeast + 1% glucose), PYI (peptone yeast + 1% inulin) and PY (peptone yeast). The&#xD;
      latter served as negative control. The LS G60 previously cultivated was included in these&#xD;
      three solutions respectively, and incubated at 30°C for 24 hours.&#xD;
&#xD;
      Spectrophotometry (Genesys 10S VIS, made Madison, USA) analyses using 600 mm for optical&#xD;
      density (OD) were performed. To measure absorbance, the solution with LS G60 was adjusted to&#xD;
      OD=1, according to the formula C1.V1=C2.V2 (C1: initial concentration, V1: initial volume,&#xD;
      C2: final concentration and V2: final volume). The measurements were performed at the initial&#xD;
      time (zero), and after 2, 4, 6, 8, 10 and 12 hours. All tests were repeated for confirmation.&#xD;
&#xD;
      Inhibition of pathogenic bacteria by Lactobacillus salivarius G60 Well diffusion test was&#xD;
      performed. Three drops of 10 ml of bacterial suspension (1x10⁸-⁹ cells/ml of LS G60) in&#xD;
      buffered saline were placed in soy triptic agar and incubated at 30°C for 3 hours under&#xD;
      optimal anaerobic conditions. The plates were covered with 10 ml of soft soy triptic agar&#xD;
      (0.7% agar) and inoculated with 1 ml of bacterial suspension (1x10⁸-⁹ cells/ml) in buffered&#xD;
      saline of halitosis-causing pathogens (Porphyromonas gingivalis and Prevotella intermedia)&#xD;
      under anaerobic conditions. They were incubated at 30°C and zones of inhibition halo of&#xD;
      microbial growth around the droplets were examined at 24, 48 and 72 hours.&#xD;
&#xD;
      Statistical analysis Data was statistically analyzed by one of the authors (SMCJ) blinded to&#xD;
      the interventions. Initial comparisons among groups of patients were done using ANOVA (age)&#xD;
      and chi-square (gender) tests. Treatment values on days 0 and 14 were first compared in each&#xD;
      group by Wilcoxon or t tests for paired data. We employed generalized linear models (GZLM) to&#xD;
      compare treatment means adjusting for pre-intervention values. The inclusion of covariable&#xD;
      gender or age was decided based on Akaike´s index. Gender entered as covariable in the&#xD;
      analysis of Halimeter, age was included in the models for OHIP-14, whereas no covariable was&#xD;
      used when analyzing organoleptic score. We used Gama distribution and log link for the&#xD;
      analyses of Halimeter and OHIP-14, as well as Poisson distribution and log link for&#xD;
      organoleptic scores and coating index. The constant 1 was added to OHIP-14 values to make&#xD;
      them amenable to the use of logarithms. Pairwise multiple comparisons among groups were made&#xD;
      using Least Significant Difference. Results from metabolization of inulin by Lactobacillus&#xD;
      salivarius G60 were analyzed using ANOVA and Tukey post hoc test. The statistical analyses&#xD;
      were performed using Graph Prism 4.0 and SPSS v.18 softwares. The limit considered for&#xD;
      statistical significance was 5%.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Halitosis Measured by Organoleptic Test</measure>
    <time_frame>Halitosis measured by organoleptic test was performed before and 14 days after the treatments</time_frame>
    <description>Unabbreviated scale title: Organoleptic test Minimum: 0 Maximum: 5 Higher score means worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coating Index</measure>
    <time_frame>Coating index was evaluted before and 14 days after the treatments.</time_frame>
    <description>Unabbreviated scale title: Coating index (evaluated by a trained judge during oral examination) Minimum: 0 Maximum: 4 Higher score means worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Halitosis Measured by Halimeter</measure>
    <time_frame>Halitosis measured by halimeter test was performed before and 14 days after the treatments</time_frame>
    <description>Unabbreviated scale title: Halitosis measured by halimeter Minimum: 0 Maximum: 500 A score =&gt;75 ppb means halitosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral-health Related Quality of Life</measure>
    <time_frame>Oral health impact profile -14 questionnaire was filled before and 14 days after the treatments</time_frame>
    <description>Unabbreviated scale title: Oral-health related quality of life measured by Oral Health Impact Profile -14 questionnaire Manimum: 0 Maximum: 56 Higher scores mean worse outcome</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Halitosis</condition>
  <condition>Tongue Diseases</condition>
  <arm_group>
    <arm_group_label>Inulin+SS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental treatment: A gum of inulin 1g plus Streptococcus salivarius 1 billion colony forming units (CFU) per oral each 12 hours for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S salivarius</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active comparator: A gum of Streptococcus salivarius 1 billion CFU per oral each 12 hours for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 1 gum per oral each 12 hours, for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inulin+SS</intervention_name>
    <description>Experimental treatment: A gum of inulin 1g plus Streptococcus salivarius 1 billion CFU per oral each 12 hours for 10 days</description>
    <arm_group_label>Inulin+SS</arm_group_label>
    <other_name>Inulin plus Streptococcus salivarius</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S salivarius</intervention_name>
    <description>Active comparator: A gum of Streptococcus salivarius 1 billion CFU per oral each 12 hours for 10 days</description>
    <arm_group_label>S salivarius</arm_group_label>
    <other_name>Streptococcus salivarius</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo 1 gum each 12 hours for 10 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients with halitosis by tongue coating;&#xD;
&#xD;
          -  participants must accept to participate in the study;&#xD;
&#xD;
          -  tongue coating identified by oral examination;&#xD;
&#xD;
          -  halitosis must be confirmed by the organoleptic test.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  halitosis for other conditions, including periodontal diseases and non-oral&#xD;
             conditions;&#xD;
&#xD;
          -  use of antibiotics in the last 30 days;&#xD;
&#xD;
          -  active smoking (&gt;10 cigarettes/day);&#xD;
&#xD;
          -  alcohol consumption (&gt;2 drinks/day);&#xD;
&#xD;
          -  report of pregnancy or breastfeeding;&#xD;
&#xD;
          -  report of systemic diseases, including diabetes, kidney failure and hepatic cirrhosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Fornari</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade de Passo Fundo</affiliation>
  </overall_official>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 15, 2016</study_first_submitted>
  <study_first_submitted_qc>June 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2016</study_first_posted>
  <results_first_submitted>August 1, 2019</results_first_submitted>
  <results_first_submitted_qc>August 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 19, 2020</results_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade de Passo Fundo</investigator_affiliation>
    <investigator_full_name>Fernando Fornari</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tongue Diseases</mesh_term>
    <mesh_term>Halitosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Inulin+LS</title>
          <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="P2">
          <title>L Salivarius</title>
          <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="P3">
          <title>Placebo</title>
          <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Inulin+LS</title>
          <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="B2">
          <title>L Salivarius</title>
          <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="B3">
          <title>Placebo</title>
          <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tongue coating (absent = 0; present = levels 1,2 and 3)</title>
          <description>Coating was described after visual inspection of the tongue and coating index was classified into 4 levels: 0 - no coating; 1 - thin coating on 1/3; 2 - thin coating on more than 1/3 or thick coating on only 1/3; 3 - thick coating on more than 1/3.</description>
          <units>Level of tongue coating</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="B2" value="2" lower_limit="2" upper_limit="2"/>
                    <measurement group_id="B3" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="B4" value="2" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Halitosis Measured by Organoleptic Test</title>
        <description>Unabbreviated scale title: Organoleptic test Minimum: 0 Maximum: 5 Higher score means worse outcome.</description>
        <time_frame>Halitosis measured by organoleptic test was performed before and 14 days after the treatments</time_frame>
        <population>Patients with oral halitosis associated with tongue coating</population>
        <group_list>
          <group group_id="O1">
            <title>Inulin+LS</title>
            <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O2">
            <title>L Salivarius</title>
            <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Halitosis Measured by Organoleptic Test</title>
          <description>Unabbreviated scale title: Organoleptic test Minimum: 0 Maximum: 5 Higher score means worse outcome.</description>
          <population>Patients with oral halitosis associated with tongue coating</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="0.68"/>
                    <measurement group_id="O2" value="3.2" spread="0.68"/>
                    <measurement group_id="O3" value="2.9" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.74"/>
                    <measurement group_id="O2" value="1.8" spread="0.78"/>
                    <measurement group_id="O3" value="1.7" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Coating Index</title>
        <description>Unabbreviated scale title: Coating index (evaluated by a trained judge during oral examination) Minimum: 0 Maximum: 4 Higher score means worse outcome.</description>
        <time_frame>Coating index was evaluted before and 14 days after the treatments.</time_frame>
        <population>Patients with oral halitosis associated with tongue coating</population>
        <group_list>
          <group group_id="O1">
            <title>Inulin+LS</title>
            <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O2">
            <title>L Salivarius</title>
            <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Coating Index</title>
          <description>Unabbreviated scale title: Coating index (evaluated by a trained judge during oral examination) Minimum: 0 Maximum: 4 Higher score means worse outcome.</description>
          <population>Patients with oral halitosis associated with tongue coating</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.56"/>
                    <measurement group_id="O2" value="2.1" spread="0.52"/>
                    <measurement group_id="O3" value="2.0" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.49"/>
                    <measurement group_id="O2" value="1.7" spread="0.70"/>
                    <measurement group_id="O3" value="1.4" spread="0.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Halitosis Measured by Halimeter</title>
        <description>Unabbreviated scale title: Halitosis measured by halimeter Minimum: 0 Maximum: 500 A score =&gt;75 ppb means halitosis.</description>
        <time_frame>Halitosis measured by halimeter test was performed before and 14 days after the treatments</time_frame>
        <population>Patients with oral halitosis associated with tongue coating</population>
        <group_list>
          <group group_id="O1">
            <title>Inulin+LS</title>
            <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O2">
            <title>L Salivarius</title>
            <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Halitosis Measured by Halimeter</title>
          <description>Unabbreviated scale title: Halitosis measured by halimeter Minimum: 0 Maximum: 500 A score =&gt;75 ppb means halitosis.</description>
          <population>Patients with oral halitosis associated with tongue coating</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="181" spread="93"/>
                    <measurement group_id="O2" value="197" spread="145"/>
                    <measurement group_id="O3" value="187" spread="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" spread="55"/>
                    <measurement group_id="O2" value="125" spread="71"/>
                    <measurement group_id="O3" value="149" spread="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral-health Related Quality of Life</title>
        <description>Unabbreviated scale title: Oral-health related quality of life measured by Oral Health Impact Profile -14 questionnaire Manimum: 0 Maximum: 56 Higher scores mean worse outcome</description>
        <time_frame>Oral health impact profile -14 questionnaire was filled before and 14 days after the treatments</time_frame>
        <population>Patients with oral halitosis associated with tongue coating</population>
        <group_list>
          <group group_id="O1">
            <title>Inulin+LS</title>
            <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O2">
            <title>L Salivarius</title>
            <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
          </group>
        </group_list>
        <measure>
          <title>Oral-health Related Quality of Life</title>
          <description>Unabbreviated scale title: Oral-health related quality of life measured by Oral Health Impact Profile -14 questionnaire Manimum: 0 Maximum: 56 Higher scores mean worse outcome</description>
          <population>Patients with oral halitosis associated with tongue coating</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="10.6"/>
                    <measurement group_id="O2" value="5.7" spread="6.9"/>
                    <measurement group_id="O3" value="6.7" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="7.8"/>
                    <measurement group_id="O2" value="4.9" spread="7.9"/>
                    <measurement group_id="O3" value="6.6" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 days</time_frame>
      <desc>Headache in one patient during 10 days use of Inulin + LS Tongue discomfort in two patients during 10 days use of LS Mild diarrhea in one patient during 10 days use of placebo</desc>
      <group_list>
        <group group_id="E1">
          <title>Inulin+LS</title>
          <description>Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion colony forming units (CFU) per oral each 12 hours for 10 days&#xD;
Inulin+LS: Experimental treatment: A gum of inulin 1g plus Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="E2">
          <title>L Salivarius</title>
          <description>Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days&#xD;
L salivarius: Active comparator: A gum of Lactobacillus salivarius G60 1 billion CFU per oral each 12 hours for 10 days</description>
        </group>
        <group group_id="E3">
          <title>Placebo</title>
          <description>Placebo 1 gum per oral each 12 hours, for 10 days&#xD;
Placebo: Placebo 1 gum each 12 hours for 10 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>tongue discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Mild diarrhea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Fernando Fornari</name_or_title>
      <organization>Universidade de Passo Fundo</organization>
      <phone>+555433168395</phone>
      <email>fernandofornari@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

